MARKET OPEN
PLAG 0.72 ▲ +0.07 (+10.02%)
DXF 0.37 ▼ -0.01 (-2.23%)
BURU 0.56 ▼ -0.03 (-4.46%)
DDC 0.14 ▼ -0.01 (-9.27%)
GPUS 0.14 ▲ +0.01 (+5.30%)
DNN 2.26 ▼ -0.02 (-0.88%)
SDEV 0.94 ▲ +0.06 (+6.52%)
BTG 5.27 ▼ -0.05 (-0.85%)
URG 0.85 ▲ +0.01 (+0.59%)
EQX 11.08 ▼ -0.07 (-0.63%)
PLAG 0.72 ▲ +0.07 (+10.02%)
DXF 0.37 ▼ -0.01 (-2.23%)
BURU 0.56 ▼ -0.03 (-4.46%)
DDC 0.14 ▼ -0.01 (-9.27%)
GPUS 0.14 ▲ +0.01 (+5.30%)
DNN 2.26 ▼ -0.02 (-0.88%)
SDEV 0.94 ▲ +0.06 (+6.52%)
BTG 5.27 ▼ -0.05 (-0.85%)
URG 0.85 ▲ +0.01 (+0.59%)
EQX 11.08 ▼ -0.07 (-0.63%)
Start Trading Login
Home › Stocks › Merck & Company
search.svg
Merck & Company Inc. (MRK)
New York Stock Exchange
$146.15
▲ +$0.20 (+0.13%)

Trade Merck & Company (MRK) with a $100K Funded Account

Trade MRK and top U.S. stocks through trader2B® FREE $100K Challenge. Pass and receive a live funded account after approval, with 50% of your trading profits.

FREE funded path profit split: 50% after qualification.
✓ 100% FREE
- No credit card
✓ U.S. Stocks
- Real market data*
✓ Profit Split
- 50% on FREE $100K account
✓ Trading Style
- Day Trading
100% FREE
No credit card
U.S. Stocks
Real market data*
Profit Split
50% on FREE $100K account
Trading Style
Day Trading
Start FREE $100k Challenge View MRK Chart
Merck & Company Inc. Stock Logo
MR
Open $145.00
Previous Close $145.95
Day High $147.41
Day Low $144.73
Volume $1.57M
Market Cap $360.56B

Merck & Company Financial Highlights

EPS $7.30
Revenue $65.01B
Dividend $0.85
52 Week Low $77.58
52 Week High $154.49
200 MA $114.23

Latest Merck & Company (MRK) Stock News

Recent company and market developments from original news sources.

The Winners Inside SCHD - October 2026 SeekingAlpha·Oct 19, 2026 Goldman's defensive stocks with quality-growth characteristics SeekingAlpha·Oct 18, 2026 Catalyst Watch: Meta earnings, Kroger event, and Black Monday turns 39 SeekingAlpha·Oct 16, 2026 Moderna falls ahead of cancer vaccine data next week SeekingAlpha·Oct 16, 2026 Novo Nordisk and Eli Lilly Just Got Some Fantastic News Motley Fool·Oct 16, 2026
Moderna outweighs bearish views ahead of cancer vaccine data SeekingAlpha·Oct 15, 2026 Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities - Form 25-NSE SEC Filings (All years)·Oct 15, 2026 Dow Jones Industrial Average Monitor Update - A Look At 30 U.S. Large-Caps SeekingAlpha·Oct 14, 2026 Current report pursuant to Section 13 or 15(d) - Form 8-K SEC Filings (All years)·Oct 13, 2026 BioNTech falls as mRNA therapy for head and neck cancer fails in mid-stage trial SeekingAlpha·Oct 13, 2026

About Merck & Company (MRK) Stock

Merck is committed to delivering meaningful advances for patients with melanoma and to continuing research in skin cancers through a broad clinical development program across investigational and approved medicines. KEYTRUDA has been established as an important treatment option for the adjuvant treatment of patients with resected Stage IIB, IIC, or III melanoma based on results of KEYNOTE-054 and KEYNOTE-716. KEYTRUDA is also approved worldwide for the treatment of patients with unresectable or metastatic melanoma. Leveraging a decade of melanoma clinical trials, Merck continues to explore both innovative treatment approaches, including investigational individualized neoantigen therapies, and novel KEYTRUDA combinations with the goal of further improving long-term outcomes for people living with melanoma.

Trade U.S. Stocks with trader2B

FREE $100K ToroChallenge®
Learn more →
FREE $100K trading rules
Learn more →
Eligible U.S. stocks & ETFs
Learn more →
trader2B trading platform
Learn more →
Compare ToroChallenge® funded plans
Learn more →

Merck & Company Inc. Stock Insights

View More Blog →
Uncategorized Quick-Hit Sessions bei 1Red Casino: Schnelle Runden, Klare Entscheidungen, Soforter Spaß

Einige Spieler bevorzugen es, sich auf lange Sicht einzurichten. Andere nicht. Wenn Sie der Typ...

Read article → Uncategorized Mostbet Azərbaycan – platformaya ümumi baxış

Mostbet Azərbaycan – platformaya ümumi baxış ▶️ OYNA Содержимое Qeydiyyat və hesabın yaradılması Bonus və...

Read article → Uncategorized Mostbet Azərbaycan – oyunlar və imkanlar

Mostbet Azərbaycan – oyunlar və imkanlar ▶️ OYNA Содержимое Qeydiyyat və hesab açma prosesi Depozit...

Read article →

Explore other popular U.S. stocks.

View all stocks →
TSLA logo
T
Trade Tesla Inc. Stock TSLA NVDA logo
N
Trade NVIDIA Corp Stock NVDA AAPL logo
A
Trade Apple Inc. Stock AAPL META logo
M
Trade Meta Platforms Inc. Stock META

Frequently Asked Questions About MRK Trading

FREE $100K account, trading rules, payouts, hours and algo trading.

What should traders know before trading MRK?
Merck & Company (MRK) trading conditions on the NYSE can vary significantly due to shifting daily volume and bid-ask spreads. Technical day traders often evaluate real-time order book liquidity and key chart levels, such as its 200-day moving average of $$114.23, before executing a trade.

What are the rules for day trading MRK on a funded account?
Stocks must be included on the eligible symbol list to be traded in the FREE $100K ToroChallenge®. For approved U.S. equities, regular market hours are 9:30 AM to 4:00 PM New York time. Under the trading rules, all positions must be closed before the end of the trading session; overnight holding is not permitted.

How do I qualify to trade Merck & Company Inc. (MRK) and what is the profit split?
You can start trader2B® FREE $100K evaluation with no upfront cost or credit card required. After meeting the performance requirements and passing the evaluation, you can receive a live funded account with a 50% profit split. Traders who want higher payout percentages can choose paid Funded Trader Pricing – ToroChallenge® Plans | trader2B® offering up to 95%–99% profit splits. Symbol availability depends on the eligible symbol list for each program.

Can I use algorithms or API bots to trade MRK?
Trading Merck & Company Inc. (MRK) requires the stock to be on our active eligible symbol list. For all approved equities, standard execution on the FREE $100K ToroChallenge® is manual. If you want to deploy automated bots, algorithmic strategies, or custom scripts, you can unlock API trading as an optional premium feature. Manage your keys and enable API access directly through the Trader2B add-ons page.

Why are some U.S. stocks not available to trade on trader2B®?
trader2B® limits its eligible symbol list based on liquidity, price, short-sale availability, risk, and overall market quality. Stocks with low trading volume, very low prices, wide bid-ask spreads, limited short availability, or elevated manipulation risk may be excluded from the FREE $100K ToroChallenge®. You can view the current list of approved stocks on the eligible symbol list

How and when can I withdraw profits after trading MRK on a funded account?
After passing the evaluation and being approved for a live funded account, you can request payouts based on the profit split and withdrawal rules for your program. Payout eligibility depends on maintaining the required risk limits and following the funded account rules. For current payout terms and withdrawal requirements, please review the trading rules.

What platforms can I use to trade MRK with trader2B®?
  • trader2B® WebTrader: A fast, browser-based platform requiring zero software downloads.
  • trader2B® Desktop: A high-performance downloadable application for Windows, macOS, and Linux, equipped with multi-monitor support, Level II data, and hotkey execution.
  • trader2B® Mobile App: Mobile trading available on both iOS (App Store) and Android (Google Play) to monitor and manage open positions on the go.
  • API Trading: Automated execution and custom algorithmic trading enabled via the optional trader2B® API add-on

How much buying power do I get to trade MRK?
Traders starting the FREE $100K ToroChallenge® are allocated up to $100,000 in intraday buying power to trade eligible U.S. equities, including Merck & Company Inc. (MRK). For traders seeking greater capital scaling, our advanced paid tiers provide up to $250,000 in total buying power with flexible account reset options. You can compare all available capital allocations and upgrade paths directly on our plans page.

Can I get a higher profit split than the FREE $100K Challenge?
Yes. Traders who want a higher potential profit split can choose a paid ToroChallenge® plan: Toro25 up to 95%, Toro100 up to 97%, and Toro250 up to 99%. Compare ToroChallenge® plans.

Can I use algo orders or automated trading to trade MRK?
The FREE $100K ToroChallenge® does not permit bots, API trading, or automated/algo trading strategies. Algo or API availability on other ToroChallenge® programs depends on the specific plan, platform and applicable rules.

Ready to trade Merck & Company stock with trader2B® capital?

Start the FREE $100K ToroChallenge® and trade eligible U.S. stocks including MRK.

Start FREE $100K Challenge →
100% FREE · No credit card · Day trading